ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2023

News provided by

Mar 03, 2023, 05:13 ET

Zinzino group revenue increased with a total of 24%, compared with the previous year.

GOTHENBURG, Sweden, March 3, 2023 /PRNewswire/ -- The revenue in February for Zinzino's sales markets increased by 23 % and amounted to SEK 109.6 (89.0) million. Faun Pharma's external sales increased by 34 % and amounted to SEK 8.7 (6.5) million. Overall, the Group increased revenues by 24 % to SEK 118.3 (95.5) million compared with the previous year.

Accumulated revenue for January - February 2023 increased by 21% to SEK 247.7 (204.5) million.

Revenues were distributed as follows:

Regions,MSEK	23-Feb	22-Feb	Change	YTD 2023	YTD 2022	Change
The Nordics	23.2	21.5	8 %	46.7	47.5	-2 %
Central Europe	26.9	18.5	45 %	55.4	36.9	50 %
East Europe	25.2	23.3	8 %	58.0	52.0	12 %
South & West Europe	14.4	11.2	29 %	30.3	23.3	30 %
The Baltics	6.0	5.2	15 %	13.4	11.6	16 %
North America	6.5	4.3	51 %	12.8	8.7	47 %
Asia-Pacific	6.4	4.6	39 %	10.9	10.3	6 %
Africa	1.0	0.4	150 %	2.4	0.8	200 %
Zinzino	109.6	89.0	23 %	229.9	191.1	20 %
Faun Pharma	8.7	6.5	34 %	17.8	13.4	33 %
Zinzino Group	118.3	95.5	24 %	247.7	204.5	21 %

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA
Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
Africa: South Africa